>In early August, soon after joining the FDA, Tidmarsh announced actions that would effectively remove from the market a drug ingredient made by a company associated with Tang. Tidmarsh’s lawyer then sent a letter to Tang proposing that he extend a “service agreement” for “another 10 years,” which would see Tang making payments to a Tidmarsh-associated entity until 2044. The email was seen as attempted extortion, with such payments being in exchange for Tidmarsh rolling back the FDA’s regulatory change.
“He had the temerity to reject a drug that had lousy data…”
Was that data really “lousy”? (Referencing the REPL data?)
Was it a trial design issue? (which he has very strong and unconventional opinions on)
Is it the role of his position to overrule his specialist review teams ? (in the absence of any clear safety risks or malfeasance)
This. They don’t get paid much, or much glory if any, but overall they are smart and hard working and are eager to have rational and data driven discussions about the programs they oversee. Current status is heartbreaking.
And they are slowly being attrited by layoffs, being led by corrupt shitbirds, and the Russell Vought ethos of making career public servants miserable.
Yep, this is not the first time I have read the first few paragraphs of an article by her and told myself: why should I care about this partisan political bullshit.
People like like to pretend their favorite side doesn't do as much bullshit, yet they do, even if it's more subtle or hidden.
What a waste of time. Complaining about the drama while creating it...
You have to be kidding me. A division director of FDA was extorting people mafia style, with links to a lawsuit with evidence and your first thoughts were: "she hurt me feefees with a article about inane culture war bullshit" and "how dare she display her twiter-clone account".
19 comments
[ 3.9 ms ] story [ 43.7 ms ] threadStraight up extortion.
How randomly they seem to be applied to makes me wonder if theres back room deals going on.
Was that data really “lousy”? (Referencing the REPL data?) Was it a trial design issue? (which he has very strong and unconventional opinions on) Is it the role of his position to overrule his specialist review teams ? (in the absence of any clear safety risks or malfeasance)
There's plenty to criticize of the org (as with almost all others) but the rank and file are doing good work to help try to keep us safe.
People like like to pretend their favorite side doesn't do as much bullshit, yet they do, even if it's more subtle or hidden.
What a waste of time. Complaining about the drama while creating it...
You have to be kidding me. A division director of FDA was extorting people mafia style, with links to a lawsuit with evidence and your first thoughts were: "she hurt me feefees with a article about inane culture war bullshit" and "how dare she display her twiter-clone account".
As always, https://www.jwz.org/ is right.